NEW YORK, July 29 (Our New York News) — The biggest change AI may bring to healthcare by the end of the decade is not a robot replacing a doctor. It is more likely to be care that starts earlier, fits a person more closely, and uses more data to make decisions.
An IEEE report says the areas with the strongest promise are personalized medicine, genetic engineering and gene therapy, and accessible early disease diagnostics and biomarkers. In the report, those categories scored highest for impact, likelihood of success, maturity, and adoption.
For most people, that could affect basic parts of care: when a disease is found, how a treatment is chosen, and how often a patient needs to come in for follow-up. Biomarkers are measurable signs in the body, such as proteins or genes, that can help show whether disease is present or how it may change. Gene therapy aims to treat disease by changing genes or how genes work.
What the IEEE report expects
The report says health-tech advances over the next five to 10 years could help reduce preventable chronic diseases, improve personalized clinical outcomes, improve food safety, and widen access to high-quality, nutrient-dense foods. It also points to molecular therapeutics, protein synthesis, and better understanding of life as areas that could advance healthcare.
The report does not present AI as a cure-all. It treats AI as one part of a wider system that includes biotechnology, digital health, agricultural drones, and personalized nutrition.
How AI is already being used
Peer-reviewed reviews in PubMed Central say AI is already being used in modern medicine for disease detection, personalized care, drug discovery, predictive analytics, telemedicine, and wearable health technologies. Those reviews say AI can analyze electronic health records, medical imaging, and genomic profiles to find patterns, predict how disease may progress, and suggest better-fit treatments.
That matters because these are the building blocks of precision medicine, a model that uses a patient’s biology and health history to guide care more precisely. A PubMed Central review says AI and precision medicine are converging in ways that could improve the amount of highly personalized diagnostic and therapeutic information available to clinicians and patients.
Another review says AI-enabled tools may improve diagnostic accuracy, optimize treatment strategies, and improve patient outcomes. It also says AI use in multi-omics integration, wearable technology, and precision therapies could change how healthcare is delivered. Multi-omics means combining several layers of biological data, such as genes, proteins, and other molecular signals.
What may change first
A separate PubMed Central article lays out a timeline for AI in healthcare. It says precision diagnostics, precision therapeutics, and precision medicine are among the near-term ways AI could reshape care. It places precision imaging in the short term, with larger-scale precision imaging, synthetic biology, immunomics, and customized healthcare in the medium term. Longer-term uses could include genomics medicine, AI-driven drug discovery, and new curative treatments.
That timeline suggests the earliest changes may show up in screening and diagnosis. In practical terms, that could mean a scan, test, or health record gets reviewed faster and with more context than before. It could also mean treatment plans are matched more closely to a person’s biology instead of relying only on broad averages.
What could slow it down
The IEEE report says the main barriers are privacy and security concerns around health data used for public-health prevention through epidemiology and surveillance, along with a status-quo culture in healthcare.
Those barriers matter because AI depends on large amounts of sensitive information. If health systems cannot protect that data, or if hospitals are slow to adopt new tools, even promising systems may take longer to reach everyday care.
The report also shows that the future of AI in health is not just about clinics and hospitals. It ties health technology to food systems and personalized nutrition as well. Dejan Milojicic, chair of the IEEE Future Directions Committee Industry Advisory Board, said health technologies are among the most transformative because they move care from reactive treatment toward proactive protection.
What this does not mean yet
The research does not say AI will take over medicine by itself. It points to tools that can help doctors, researchers, and health systems make faster and more tailored decisions.
For patients, the likely change is a steadier one: more early detection, more personalized treatment, and more monitoring between visits. The bigger question is not whether AI will affect healthcare. It is how quickly the technology can prove it is accurate, secure, and useful enough to become part of routine care.
